Results A total of 7 cross-sectional studies provided data on 4057 children. The pooled Sn, Sp, DOR and SROC-AUC for the overall diagnostic accuracy of ADOS M1 were: 0.91 (95 % CI=0.89 to 0.93), 0.73 (95 % CI=0.69 to 0.76), 44.20 (95 % CI=15.89 to 122.95) and 0.90 respectively. Conclusions It is concluded that ADOS M1 with the original diagnostic algorithm has the overall diagnostic accuracy and pooled specificity suggesting moderate accuracy. The pooled sensitivity is high to be used as a screening test for Autism Spectrum Disorders. ADOS M1 with the revised diagnostic algorithm should be used for diagnostic purpose.
Results

Pooled sensitivity (95 % CI, I
2 for heterogeneity) for detecting DSM-IV/IV-TR or best estimate diagnosis of ASD was 0.91 (95 % CI=0.89 to 0.93, I
2 =92.8 %). Pooled specificity, calculated using data from all the studies, was 0.73 (95 % CI=0.69 to 0.76, I 2 =90.3 %). Figure 2 shows the Forest plots for the pooled sensitivity and specificity. The pooled Diagnostic Odds Ratio was 44.26 (95 % CI=15.89 to 122.95, I 2 =85.3 %) ( Table 2) . A graph of the SROC curve of ADOS M1 showing the sensitivity (true-positive rates) vs. specificity (false-positive rates) from individual studies is shown in Fig. 3 . The Area Under the Curve (AUC-SROC) was 0.90. Similarly, the data showed that the maximum joint sensitivity and specificity (the Q-value) was also 0.82 and thus was close to the diagonal line of the SROC curve.
As the heterogeneity scores associated with the pooled diagnostic accuracy parameters was significant (I 2 ranged from 95-92 %), the dichotomized QUADAS-2 scores representing the quality of the study and sample size was regressed against the DOR (effect size) as the dependent variable as planned. The pooled DOR value of 44.26 (95 % CI=15.891 to 122.95, I 2 =85.3 %) in the bivariate analysis remained the same after adjusting for the sample size [RDOR=1(95%CI=0.99 to 1); P=0.8] and quality of the studies [with the RDOR=0.22(95%CI=0 to 38.47); P=0.4] was adjusted in the meta-regression demonstrating the modifying effect of these two factors on the diagnostic accuracy of ADOS M1 . Pooled DOR for detecting ASD among good-quality studies was 73.42 (95 % CI=11.16 to 482.83); I 2 =90.4 %, Tausquared was 0.92. Among poor-quality studies the pooled DOR was found to be 29 (95 % CI=8.46 to 99.34); I 2 = 78.6 %, Tau-squared was only 1.27. Pooled DOR for detecting ASD among studies with large-sampled studies was 68 (95 % CI=19.58 to 237.51); I 2 =79.1 %, Tau-squared was 1.27. Among small-sampled studies the pooled DOR was found to be 21.09 (95 % CI=5.23 to 84.98); I 2 =82.7 %, Tau-squared was 1.08.
The need to use the ADOS M1 with the revised diagnostic algorithm thus becomes a necessity for diagnostic utility. The above stand is supported by the finding that pooled sensitivity and specificity of the ADOS M1 were 0.91, 0.72, respectively, indicating a high sensitivity and moderate specificity.
Discussion
The AUC-SROC for ADOS M1 in diagnosing ASD was 90. Studies with AUC's values of 0.50 to 0.70 are generally considered of low accuracy, 0.70 to 0.90 as having moderate accuracy, and those with AUC≥0.90 as highly accurate [15] . In addition, the index data showed that the maximum joint sensitivity and specificity (the Q-value) was 0.82 and thus was close to the diagonal line of the SROC curve suggesting that ADOS M1 is a moderately to highly informative test.
Also, the diagnostic odds ratio (DOR) calculated from sensitivity and specificity was 44.2 which dropped only insignificantly when adjusted for the quality of the study and the sample size. In theory, the DOR ranges in value from zero to infinity, with higher values indicating better discriminatory performance of the test. The DOR of 44 for ADOS M1 implies that it has the possibility of correctly diagnosing cases of ASD by 44-folds. Thus it is far better than any random test at diagnosing ASD, even when adjusted for the quality of the study and the sample size, among young children.
The subgroup analysis showed that the pooled DOR was better with high quality studies than poor quality studies. The index analysis to understand this difference showed that the estimate between the study variance (Tau-squared) was lower among studies in the high quality study group at 0.92 when compared with the poor quality study group at 1.27, suggesting the heterogeneity in the high quality group was far less compromising the DOR in that group. For a similar reason of heterogeneity, the pooled DOR for the large-sampled studies was better than large-sampled study (Tau-squared for smallsampled study vs. large sampled study=1.27 vs. 1.08). It is concluded, despite the above caveats, that further studies are needed to support the use the original diagnostic algorithm of ADOS M1 as the gold standard measure for diagnosing ASD in young children. This metaanalysis raises questions as to whether the ADOS M1 cut-off score needs further modification and in the meantime the revised diagnostic algorithm of ADOS M1 needs to be used for the confirmation of the diagnosis of Autism Spectrum Disorders in the clinical and educational settings. 
